RARE Competitors & Alternatives
Compare Ultragenyx with similar stocks in the same industry
Biotechnology
RARE
Main Stock$14.30
Tradestie Score
49
Market Cap
$2.89B
Revenue Growth
0.3%
Analyst Upside
+88.8%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVAX
Novavax Inc
|
$9.42
|
$1.54B | - | 48 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.10
|
$1.50B | 7.1 | 53 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$38.66
|
$1.50B | - | 41 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$31.62
|
$1.49B | - | 40 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$24.59
|
$1.43B | - | 42 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$17.10
|
$1.42B | - | 41 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$18.18
|
$1.35B | - | 46 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$43.62
|
$1.32B | - | 47 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$7.45
|
$1.29B | - | 47 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$29.03
|
$1.29B | - | 57 | Compare |
More RARE Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry